Identification of a Novel 1,2,3,4-Tetrahydrobenzo[<i>b</i>][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease
Jole Fiorito(New York Institute of Technology), Donald W. Landry, Agnieszka Staniszewski(Columbia University), Faisal Saeed(Columbia University), Ottavio Arancio(Columbia University), Shijun Yan(University of Oxford), Hong Zhang(Columbia University), Shi‐Xian Deng(Columbia University), Jérémie Vendôme(Schrodinger (United States))
Cited by 59
Related Papers
Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits
|Neuron|2014|1.2k
RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice
|The EMBO Journal|2004|327
PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease
|Brain|2017|301
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
|Gastroenterology|2020|261
Enhancing Hit Discovery in Virtual Screening through Absolute Protein–Ligand Binding Free-Energy Calculations
|Journal of Chemical Information and Modeling|2023|120